There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Macroprolactinomas poorly responsive to dopamine-agonists are often more aggressive
and are usually termed 'resistant' but this clinical concept has always been defined
empirically.
[1
]
Department of Internal Medicine, Cliniques de Mont-Godinne, Mont-Godinne Hospital,
Université Catholique de Louvain, B-5530 Mont-sur-Meuse, Belgium. etienne.delgrange@uclouvain.be